Table 1a. Pre- and perioperative data.
Pre- and perioperative data | Total | PDS | PDS-MMC | P-value |
---|---|---|---|---|
Number of eyes | 296 | 151 | 145 | |
Age (years) | 80.3±6.6 | 81.05±6.1 | 79.0±6.8 | 0.0007 |
Male/ Female | 128/168 | 52/99 | 79/66 | 0.0006 |
Race | ||||
Caucasian | 284 | 148 | 136 | |
Indian | 06 | 02 | 04 | |
African | 06 | 01 | 05 | |
Preoperative glaucoma diagnoses | 0.32 | |||
Primary open- angle glaucoma | 242 | 119 | 122 | |
Normotensive glaucoma | 25 | 12 | 13 | |
Pseudoexfoliation | 24 | 08 | 16 | |
Pigmentary | 04 | 02 | 02 | |
Primary angle closure glaucoma | 12 | 10 | 02 | |
Mean follow-up (months) | 63.5±35.3 | 57.9±34.2 | 69.7±39.1 | 0.003 |
Preoperative glaucoma medications | 2.1±1.6 | 1.9±1.0 | 2.4±2.0 | 0.13 |
CD ratio | 0.84±0.1 | 0.8±0.1 | 0.85±0.1 | 0.13 |
VF mean deviation (dB) | −13.4±8.0 | −11.9±7.7* (57 patients) | −14.9±8.0* (54 patients) | 0.04 |
Intraoperative perforations | 38 | 19 | 19 | 1.0 |
Spacer device | 0.0008 | |||
High-molecular- weight viscoelastic | 77 | 52 | 25 | |
SK Gel | 168 | 64 | 104 | |
Aqua Flow | 37 | 23 | 14 | |
Esnoper | 13 | 12 | 01 | |
Healaflow | 01 | 00 | 01 |